Pacific Biosciences of California (PACB) PT Raised to $45 at Cantor Fitzgerald
Tweet Send to a Friend
Cantor Fitzgerald analyst Kyle Mikson raised the price target on Pacific Biosciences of California (NASDAQ: PACB) to $45.00 (from $25.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
